A model system for measuring comparative toxicities of cardiotoxic drugs for cultured rat heart myocytes, endothelial cells and fibroblasts. II. Doxorubicin, 5-fluorouracil and cyclophosphamide

Toxicology

Volumn 33, Issue 2, 1984, Pages 117-128

  Wenzel, D G ^a   Cosma, G N ^a  

^a UNIVERSITY OF KANSAS   (United States)

Author keywords

5 Fluorouracil; Cyclophosphamide; Doxorubicin; Endothelial cells and fibroblasts; Rat heart myocytes

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; METRONIDAZOLE;

ANIMAL EXPERIMENT; CARDIOTOXICITY; CELL CULTURE; DRUG TOXICITY; ENDOTHELIUM CELL; FIBROBLAST; HEART; HEART MUSCLE CELL; HISTOLOGY; IN VITRO STUDY; INTOXICATION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMAL; CELLS, CULTURED; COMPARATIVE STUDY; CYCLOPHOSPHAMIDE; DOXORUBICIN; FIBROBLASTS; FLUOROURACIL; HEART; LIPID PEROXIDES; MYOCARDIUM; RATS; SUPPORT, NON-U.S. GOV'T;

EID: 0021738428     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0300-483X(84)90067-2     Document Type: Article

References (28)

1. Cardiotoxicity of antineoplastic drugs
2. Daunomycin-induced cardiotoxicity in children and adults. A review of 110 cases
3. Cardiotoxicity of adriamycin and related anthracyclines
4. Overview of cardiac pathology in relation to anthracycline cardiotoxicity
5. Cardiotoxicity of 5-fluorouracil (NSC19893)
6. Examination of direct cardiac effects of 5-fluorouracil (5-FU) in the isolated dog heart
7. Activation of cyclophosphamide for in vitro testing of cell sensitivity
8. Enzymatic basis of cyclophosphamide activation by hepatic microsomes of the rat
9. Review of the metabolism and mode of action of cyclophosphamide
10. Pathology of high dose intermittant cyclophosphamide therapy
11. Acute lethal carditis caused by high-dose combination chemotherapy. A unique clinical and pathological entity
12. Comparative toxicities of cardiotoxic drugs for cultured rat heart myocytes, fibroblasts and endothelial cells. I. Emetine, chloroquine and metronidazole
13. Fine structural changes in rat myocardium induced by daunorubicin
14. Some observations on the toxicity of adriamycin (NSC 123127)
15. Adriamycin: Effect on mammalian cardiac cells in culture. I. Cell population and energy metabolism
16. Nuclear and mitochondrial effects of adriamycin in singly isolated pulsating myocardial cells
17. Effects of adriamycin on rat heart cells in culture. Increased accumulation and nucleoli fragmentation in cardiac muscle v. non-muscle cells
18. Daunomycin and adriamycin: effects on the beating rate and rhythm of single cardiac cells grown in vitro
19. Action of ouabain, oligomycin, and glucagon on cultured heart cells treated with adriamycin
20. Toxicity testing in vitro. II. Use of a microsomecultured human fibroblast system to study the cytotoxicity of cyclophosphamide
21. Observations on the metabolism of cyclophosphamide
22. Prelytic damage of red cells in filtrates from peroxidizing microsomes
23. Stimulation by adriamycin of rat heart and liver microsomal NADPH-dependent lipid peroxidation
24. Cytotoxic effects of oxygen on striated muscle
25. Lipid peroxidation and acute myocardial ischemia
26. Vitamin E retards lipoperoxidation resulting from anticancer drug administration
27. Mechanism of adriamycin cardiotoxicity: evidence for oxidative stress
28. A simplified method of evaluating dose-effect experiments